证券代码：300451 证券简称：创业慧康 公告编号：2024-035 创业慧康科技股份有限公司 第八届董事会第九次会议决议公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"或"本公司"）第八届董事 会第九次会议的通知于 2024 年 9 月 26 日以邮件、传真等方式向各位董事发出， 并于 2024 年 9 月 30 日在公司三楼会议室以现场结合通讯的方式召开。会议应到 董事 9 名，实到董事 9 名，公司部分监事、高级管理人员列席了会议。会议的召 开及表决符合《中华人民共和国公司法》《创业慧康科技股份有限公司章程》等 有关规定。 此次会议由董事长张吕峥先生主持，参会董事认真审议后，依照有关规定通 过以下几项决议： 一、审议通过了《关于提名第八届董事会非独立董事候选人的议案》 公司第八届董事会董事 KWOK WAI ANDY HO（何国伟）先生和叶江先生 因个人原因申请辞去董事职务，相应需补选非独立董事人员。根据《公司法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 ...

[Table_MainInfo] 公司研究/信息服务/软件 证券研究报告 创业慧康（300451）公司跟踪报告 2024 年 09 月 19 日 [Table_InvestInfo] 投资评级 优于大市 维持 | --- | --- | |-----------------------------------------------------------------|-----------| | 股票数据 | | | 09 [ Table_StockInfo 月 18 日收盘价（元） ] | 3.23 | | 52 周股价波动（元） | 3.06-7.96 | | 总股本 / 流通 A 股（百万股） | 1549/1527 | | 总市值 / 流通市值（百万元） | 5004/4931 | | 相关研究 | | | [Table_ReportInfo] 《 Hi-HIS 推广新阶段，盈利能力有望快速修 | | | 复》 2024.04.15 | | 市场表现 [Table_QuoteInfo] -51.67% -36.67% -21.67% -6.67% 8.33% 2023/9 2023/12 2024/ ...

证券研究报告 非金融公司|公司点评|创业慧康（300451） HI-HIS 系统助力，AI 打造智慧医疗生 态 请务必阅读报告末页的重要声明 glzqdatemark1 2024年09月02日 证券研究报告 |报告要点 创业慧康发布 2024 年半年度报告，2024 年上半年公司实现营收 7.27 亿元，同比增长 3.17%； 归母净利润 0.27 亿元，同比增长 14.03%；扣非归母净利润 0.25 亿元，同比增长 36.77%；毛 利率为 54.21%，同比增长 2.32pct。2024 年第二季度公司实现营收 3.51 亿元，同比减少 1.32%； 归母净利润 0.15 亿元，同比增长 10.22%；扣非归母净利润 0.16 亿元，同比增长 28.98%；毛 利率为 56.98%，同比增加 5.11pct。 |分析师及联系人 黄楷 陈安宇 SAC：S0590522090001 SAC：S0590523080004 请务必阅读报告末页的重要声明 1 / 5 非金融公司|公司点评 glzqdatemark2 2024年09月02日 创业慧康(300451) HI-HIS 系统助力，AI 打造智慧医疗生态 ...

本报告仅供 Choice 东方财富 使用，请勿传阅。 证券研究报告 行业应用软件 公司快报 2024 年 08 月 31 日 创业慧康(300451.SZ) 大订单高速增长，与飞利浦合作进展顺利 事件概述： 8 月 29 日，创业慧康发布《2024 年半年度报告》。2024 年上半年， 公司实现营业收入 7.27 亿元，同比增长 3.17%，其中医疗行业业务 实现营收 6.93 亿元，同比增长 8.61%；实现归母净利润 2,737.6 万 元，同比增长 14.03%；扣非归母净利润 2,521.7 万元，同比增长 36.77%。 24H1 毛利率提升，大订单同比高速增长 分业务来看，①软件销售业务收入为 2.87 亿元（YoY+0.02%），毛利 率 62.18%（YoY+0.18pct）。②技术服务收入为 2.93 亿元（YoY+9%）， 毛利率 65.67%（YoY+2.7pct），其中医疗软件服务收入为 2.65 亿元 （YoY+14.6%），毛利率 67.13%（YoY+2.33pct）。③系统集成收入为 7966.61 万元（YoY+9.53%），毛利率 12.63%（YoY+4.83pct）。公 ...

Financial Performance - Revenue for the reporting period was RMB 726.74 million, a year-on-year increase of 3.17%[10] - Net profit attributable to shareholders of the listed company was RMB 27.38 million, a year-on-year increase of 14.03%[10] - Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 25.22 million, a year-on-year increase of 36.77%[10] - Operating cash flow was negative RMB 192.45 million, a year-on-year decrease of 12.33%[10] - Total assets at the end of the reporting period were RMB 5.72 billion, a year-on-year decrease of 1.28%[10] - Shareholders' equity attributable to the listed company at the end of the reporting period was RMB 4.63 billion, a year-on-year increase of 0.58%[10] - Basic earnings per share were RMB 0.02, unchanged from the same period last year[10] - Weighted average return on equity was 0.59%, an increase of 0.07 percentage points year-on-year[10] - Revenue for the reporting period was 727 million yuan, a year-on-year increase of 3.17%, with medical industry revenue reaching 693 million yuan, up 8.61% year-on-year[27] - Orders exceeding 30 million yuan increased by 110.83% compared to the same period last year[28] - The company's operating revenue for the first half of 2024 was 726.74 million yuan, a year-on-year increase of 3.17%[44] - The company's R&D investment in the first half of 2024 was 164.97 million yuan, a year-on-year increase of 3.29%[44] - The company's software sales revenue was 287.35 million yuan, with a gross profit margin of 62.18%[45] - The company's technical service revenue was 292.69 million yuan, with a gross profit margin of 65.67%[45] - The company's medical software service revenue was 264.76 million yuan, with a gross profit margin of 67.13%[46] - Medical industry revenue increased by 8.61% YoY to 692,741,222.34 RMB, with a gross margin of 54.27%[47] - Software sales revenue grew slightly by 0.02% YoY to 287,346,830.67 RMB, with a gross margin of 62.18%[47] - Technical services revenue rose by 9.00% YoY to 292,692,898.30 RMB, with a gross margin of 65.67%[47] - Medical software services revenue surged by 14.60% YoY to 264,760,707.36 RMB, with a gross margin of 67.13%[47] - Northwest region revenue increased significantly by 76.14% YoY to 85,299,929.89 RMB, with a gross margin of 63.56%[47] - Total operating revenue for the first half of 2024 reached 726,735,755.07 yuan, an increase from 704,387,729.02 yuan in the same period last year[109] - Net profit for the first half of 2024 was 31,659,124.99 yuan, up from 25,653,107.18 yuan in the first half of 2023[110] - R&D expenses increased to 138,166,674.71 yuan in the first half of 2024, compared to 120,996,405.15 yuan in the same period last year[110] - Operating profit for the first half of 2024 was 30,091,181.93 yuan, compared to 20,908,089.16 yuan in the same period last year[110] - Comprehensive income for the first half of 2024 totaled RMB 31,319,447.51, compared to RMB 25,983,946.98 in the same period last year[111] - Net profit attributable to the parent company for the first half of 2024 was RMB 27,036,273.13, up from RMB 24,338,150.24 in the same period last year[111] - Operating income for the first half of 2024 was RMB 594,092,145.56, a slight increase from RMB 577,028,362.28 in the same period last year[112] - R&D expenses for the first half of 2024 increased to RMB 112,581,604.78, up from RMB 107,921,651.77 in the same period last year[112] - Net cash flow from operating activities for the first half of 2024 was RMB 601,541,998.60, slightly down from RMB 605,084,999.23 in the same period last year[114] - Cash received from sales of goods and services for the first half of 2024 was RMB 557,660,669.51, compared to RMB 561,888,724.54 in the same period last year[114] - Cash paid for goods and services for the first half of 2024 was RMB 326,228,627.91, up from RMB 321,840,298.16 in the same period last year[114] - Cash paid to employees for the first half of 2024 increased to RMB 320,765,378.18, compared to RMB 295,281,489.50 in the same period last year[114] - Other comprehensive income after tax for the first half of 2024 was a loss of RMB 339,677.48, compared to a gain of RMB 330,839.80 in the same period last year[113] - Total comprehensive income for the first half of 2024 was a loss of RMB 4,996,020.88, compared to a loss of RMB 3,849,709.33 in the same period last year[113] - Operating cash flow for the first half of 2024 was -192.45 million yuan, a decrease compared to -171.33 million yuan in the same period last year[115] - Investment cash flow for the first half of 2024 was -128.51 million yuan, an improvement from -180.27 million yuan in the same period last year[115] - Financing cash flow for the first half of 2024 was -19.51 million yuan, compared to -42.53 million yuan in the same period last year[115] - Total cash and cash equivalents at the end of the period were 746.96 million yuan, down from 1.08 billion yuan at the end of the same period last year[115] - Parent company's operating cash flow for the first half of 2024 was -150.18 million yuan, compared to -55.26 million yuan in the same period last year[116] - Parent company's investment cash flow for the first half of 2024 was -123.08 million yuan, an improvement from -187.22 million yuan in the same period last year[117] - Parent company's financing cash flow for the first half of 2024 was -17.38 million yuan, compared to -117.20 million yuan in the same period last year[117] - Total cash and cash equivalents of the parent company at the end of the period were 325.90 million yuan, down from 681.72 million yuan at the end of the same period last year[117] - Total owner's equity at the end of the period was 4.66 billion yuan, with minority shareholders' equity accounting for 57.90 million yuan[118] - Comprehensive income for the period was -339,677.48, with a total comprehensive income of 27,375,950.61 and a net comprehensive income of 31,319,447.51[119] - Owner's equity increased by 15,136,461.43 due to owner's investment and capital reduction, primarily from share-based payments[119] - Profit distribution amounted to -15,444,264.92, reflecting the allocation to owners (or shareholders)[119] - The company's total equity at the end of the period was 4,694,895.18, with a minority interest of 62,186,297.72[120] - The initial balance of the period showed total equity of 4,601,787,992.71, with a minority interest of 8,126,624.52[121] - Changes in equity during the period included a decrease of 210,600.00 in share capital and an increase of 30,113,541.65 in capital reserve[121] - Comprehensive income for the period contributed 24,338,150.24 to the total equity, with a minority interest of 1,645,796.74[121] - Share-based payments accounted for 29,743,763.58 of the owner's equity increase[122] - The company's total equity at the end of the period was 4,672,970,316.94, with a minority interest of 39,796,588.65[123] - The company's total owner's equity at the beginning of the period was 4,257,548,105.38 yuan, with a capital reserve of 1,660,979,352.00 yuan and retained earnings of 945,567,359.51 yuan[124] - During the period, the company's comprehensive income totaled -4,996,020.88 yuan, with a decrease in retained earnings of 20,100,608.32 yuan[124] - The company's total owner's equity at the end of the period was 4,252,244,281.01 yuan, with a capital reserve of 1,676,115,813.43 yuan and retained earnings of 925,466,751.19 yuan[125] - The company's total owner's equity at the beginning of the previous period was 4,329,102,036.75 yuan, with a capital reserve of 1,634,031,569.77 yuan and retained earnings of 1,008,283,269.37 yuan[127] - During the previous period, the company's comprehensive income totaled -3,849,709.33 yuan, with a decrease in retained earnings of 19,649,029.37 yuan[127] - The company's total owner's equity at the end of the previous period was 4,340,453,995.87 yuan, with a capital reserve of 1,664,145,111.42 yuan and retained earnings of 988,543,345.04 yuan[128] - The company's registered capital is 1,549,124,692.00 yuan, with a total of 1,549,124,692 shares (1 yuan per share)[129] - The company's main business includes software sales, system integration, and technical services[129] - The company's financial statements are prepared on a going concern basis, with no significant doubts about its ability to continue operations for the next 12 months[130][131] - The company's accounting policies and estimates cover areas such as financial instrument impairment, fixed asset depreciation, and revenue recognition[133] - The company uses RMB as its functional currency[137] - Significant items are defined as those exceeding 0.5% of total assets, including bad debt provisions, prepayments, and capital R&D projects[138] - Subsidiaries and joint ventures are considered significant if their profit or assets exceed 15% of the group's total[139] - The company follows specific accounting methods for both same-control and non-same-control business combinations[140] - Control is determined based on power over investees, variable returns, and ability to influence returns[141] - The company classifies joint arrangements as either joint operations or joint ventures and accounts for them accordingly[142] - Cash equivalents are defined as short-term, highly liquid investments that are readily convertible to known amounts of cash[143] - Foreign currency transactions are translated using the spot exchange rate at the transaction date, with exchange differences recognized in profit or loss[144][145] - Financial assets are classified into three categories at initial recognition: (1) measured at amortized cost, (2) measured at fair value with changes in other comprehensive income, and (3) measured at fair value with changes in current profit or loss[146] - Financial liabilities are classified into four categories at initial recognition: (1) measured at fair value with changes in current profit or loss, (2) financial liabilities from transferred financial assets that do not meet derecognition criteria, (3) financial guarantee contracts and loan commitments not classified as (1), and (4) measured at amortized cost[146] - Financial assets measured at amortized cost are subsequently measured using the effective interest method, with gains or losses recognized in current profit or loss upon derecognition, reclassification, or impairment[146] - Financial assets measured at fair value with changes in other comprehensive income (debt instruments) are subsequently measured at fair value, with interest income, impairment losses, and exchange differences recognized in current profit or loss[146] - Financial assets measured at fair value with changes in current profit or loss are subsequently measured at fair value, with all gains or losses recognized in current profit or loss unless part of a hedging relationship[147] - Financial liabilities measured at fair value with changes in current profit or loss are subsequently measured at fair value, with changes due to the company's own credit risk recognized in other comprehensive income[147] - Financial assets are derecognized when the contractual rights to cash flows expire or when the asset is transferred and meets derecognition criteria under accounting standards[148] - The company uses a three-level hierarchy to determine the fair value of financial instruments, prioritizing observable market data[148] - The company recognizes expected credit losses for financial assets measured at amortized cost, debt instruments measured at fair value with changes in other comprehensive income, and certain other financial instruments[148] - For financial assets with credit impairment, the company recognizes changes in expected credit losses over the entire life of the asset as a loss provision[149] - The expected credit loss rate for commercial acceptance bills within 1 year is 5.00%[151] - The expected credit loss rate for accounts receivable/contract assets within 1 year is 5.00%[151] - The expected credit loss rate for other receivables within 1 year is 5.00%[151] - The expected credit loss rate for commercial acceptance bills between 1-2 years is 20.00%[151] - The expected credit loss rate for accounts receivable/contract assets between 1-2 years is 20.00%[151] - The expected credit loss rate for other receivables between 1-2 years is 20.00%[151] - The expected credit loss rate for commercial acceptance bills between 2-3 years is 30.00%[151] - The expected credit loss rate for accounts receivable/contract assets between 2-3 years is 30.00%[151] - The expected credit loss rate for other receivables between 2-3 years is 30.00%[151] - The expected credit loss rate for commercial acceptance bills between 3-4 years is 50.00%[151] - The company uses the cost method for subsequent measurement of long-term equity investments in subsidiaries and the equity method for investments in associates and joint ventures[156] - For step-by-step disposal of subsidiary investments leading to loss of control, the company assesses whether the transactions constitute a "package deal" based on factors such as transaction terms, consideration, and economic impact[157] - When control over a subsidiary is lost, the remaining equity is remeasured at fair value, and the difference between the consideration received and the share of net assets is recognized in investment income[157] - Investment properties are initially measured at cost and subsequently measured using the cost model, with depreciation or amortization calculated similarly to fixed assets and intangible assets[159] - Fixed assets are depreciated using the straight-line method with varying useful lives: buildings (20-50 years), machinery (3-10 years), vehicles (5-10 years), and other equipment (3-10 years)[161] - Construction in progress is recognized when economic benefits are probable and costs are reliably measurable, and is transferred to fixed assets upon reaching intended use status[162] - Borrowing costs are capitalized when directly attributable to the acquisition, construction, or production of qualifying assets, and capitalization ceases when the asset is ready for use[164] - Intangible assets such as land use rights, software licenses, patents, and franchises are amortized using the straight-line method over their estimated useful lives (5-50 years)[166] - R&D expenses include personnel costs, direct input costs, depreciation, and intangible asset amortization, with allocation based on project hours and usage[167] - Internal R&D project expenditures are classified into research and development phases, with development phase costs capitalized as intangible assets if specific criteria are met[167] - Long-term assets are tested for impairment at each balance sheet date, with impairment losses recognized if the recoverable amount is below the carrying value[169] - Long-term prepaid expenses are amortized over their beneficial period, with any non-beneficial amounts written off immediately[170] - Contract liabilities represent obligations to transfer goods or services to customers for which consideration has been received or is receivable[171] - Short-term employee benefits are recognized as liabilities and expensed during the period the employee provides service[172] - Post-employment benefits are classified into defined contribution and defined benefit plans, with defined benefit obligations measured using actuarial assumptions[173] - Termination benefits are recognized when the company can no longer unilaterally withdraw the offer or when restructuring costs are recognized[174] - Other long-term employee benefits are treated similarly to defined benefit plans, with costs recognized in the period incurred[175] - Provisions are recognized for obligations arising from guarantees, litigation, product warranties, and onerous contracts, measured at the best estimate of the expenditure required[176] - The company recognizes revenue for software sales at a point in time when the company completes its performance obligations and the customer confirms acceptance, payment is received, or the right to receive payment is established, and related economic benefits are likely to flow in[180][181] - Technical services, including software development and hardware/software maintenance, are recognized as revenue at a point in time for software development and over time for maintenance services based on the progress of the service period[180][181] - System integration services, including computer information equipment system integration and intelligent network cabling engineering integration, are recognized as revenue at a point in time for equipment integration and over time for cabling projects based on the actual progress of the project[180][181] - The company assesses contracts at the start date to identify individual performance obligations and determine whether they are satisfied over time or at a point in time[179] - Revenue is measured based on the transaction price allocated to each performance obligation, excluding amounts collected on behalf of third parties or expected to be refunded to customers[179] - For contracts with variable consideration, the company estimates the transaction price using the expected value or most likely amount, ensuring it does not exceed the amount that is highly probable of not reversing[179] - Contracts with significant

到目前的一个大家的一个对于我们在目前的一个经营状况的一个大致的分享另外呢我也想跟大家再继续更新一下因为前期也能看到对于电子定位的一些评级的一些变化包括它标准的这样的一些变化和名称的变化包括它可能设计的一些范围有相相相应的一些增加可能设计了原来就不太去在整个评级过程当中也增加了相应的这种范围比如说它的一个互联互通啊然后一些 就是新一创的要求国产化的适配也包括了相应的一些人工智能的一些方面的增加所以这个呢其实会在我们接下来对于医疗机构的就是电子病例评级当中会去将原来可能会涉及这些新进化建设当中的可选项变成了必选项 所以在我们接下来的信息化建设过程当中对于已经在排队做电子病例评级的他可能接下来就是部立的专家下来做相应的这个电子病例评级的时候他的侧重点他的观察点可能会向这个新的标准当中去做相应的设计那这个会在我们接下来对于院站的新化建设当中去做及时的补充和完善但是对于我们现在目前大家所关心的就是说是否因为这些 刘仲敬 明年的整个院端的电子病历的这种需求上来看或者说它针对于这些新的标准的变化它去逐渐完善更多的一些新型化建设的需求上来看它可能会有适量的增加但是量级我们觉得应该也不会是特别大会有适当的变化因为跟大家在分享交 ...

创业慧康科技股份有限公司 相关治理制度修订对照表 创业慧康科技股份有限公司于 2024 年 6 月 7 日召开了第八届董事会第七次 会议，对《董事、监事和高级管理人员持有和买卖本公司股票管理制度（2022 年 4 月）》进行了修订。修订的条款及具体内容如下： | 修订前 | | 修订后 | | --- | --- | --- | | 第一章 为加强对创业慧 | 第一条 | 第一章 第一条 为加强对创业慧 | | 康科技股份有限公司（以下简称"公司" | | 康科技股份有限公司（以下简称"公司" | | 或"本公司"）董事、监事和高级管理人 | | 或"本公司"）董事、监事和高级管理人 | | 员所持本公司股份及其变动的管理，根 | | 员所持本公司股份及其变动的管理，根 | | 据《公司法》《证券法》《上市公司股 | | 据《公司法》《证券法》和中国证券监 | | 东、董监高减持股份的若干规定》《深 | | 督管理委员会（以下简称"中国证监 | | 圳证券交易所上市公司股东及董事、监 | | 会"）《上市公司董事、监事和高级管 | | 事、高级管理人员减持股份实施细则》 | | 理人员所持本公司股份及其变动管 ...

证券代码：300451 证券简称：创业慧康 公告编号：2024-030 创业慧康科技股份有限公司 关于对外出租闲置物业的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、交易概述 1、根据创业慧康科技股份有限公司（以下简称"公司"）的战略和业务发展 需要，公司主要办公地址拟由浙江省杭州市滨江区长河街道越达巷 92 号迁移至浙 江省杭州市滨江区浦沿街道坚塔街 708 号，公司新办公地址建筑面积约为 5 万平方 米，搬迁后有利于进一步提升公司整体运营效率及实现业务协同发展。 为优化资源配置，提高资产使用效益，实现闲置资产的再利用，同时，为深入 贯彻国家和地方政府对创新创业的政策导向，积极构建全方位支持和资源的综合性 服务平台，推动产业集群化、规模化发展，助力创新创业生态的蓬勃成长，促进企 业间建立互利共赢的合作关系，共同推动建立高水平产业园，进一步激发市场活力， 提升区域经济竞争力，为公司的可持续发展注入新动力。公司于 2024 年 6 月 7 日 召开第八届董事会第七次会议、第八届监事会第六次会议，审议通过了《关于对外 出租闲置物业的议案》，同意公司授权全资 ...

创业慧康科技股份有限公司 董事、监事和高级管理人员持有和买卖 本公司股票管理制度 二○二四年六月 第四条 公司董事、监事和高级管理人员所持本公司股份在下列情形下不得 转让： （一）本人离职后六个月内； 第一章 总 则 第一条 为加强对创业慧康科技股份有限公司（以下简称"公司"或"本公 司"）董事、监事和高级管理人员所持本公司股份及其变动的管理，根据《公司 法》《证券法》和中国证券监督管理委员会（以下简称"中国证监会"）《上市 公司董事、监事和高级管理人员所持本公司股份及其变动管理规则》以及深圳证 券交易所（以下简称"深交所"）《深圳证券交易所上市公司自律监管指引第 18 号——股东及董事、监事、高级管理人员减持股份》等规定，特制定本制度。 第二条 公司董事、监事和高级管理人员所持本公司股份，是指登记在其名 下和利用他人账户持有的所有本公司股份。 公司董事、监事和高级管理人员从事融资融券交易的，其所持本公司股份还 包括记载在其信用账户内的本公司股份。 第三条 公司董事、监事和高级管理人员及本制度第七条规定的自然人、法 人或其他组织持有及买卖本公司股份的，应当遵守本制度的有关规定进行股份买 卖行为。 公司及董事、 ...

证券代码：300451 证券简称：创业慧康 公告编号：2024-031 创业慧康科技股份有限公司 第八届监事会第六次会议决议公告 本公司及监事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"或"本公司"）第八届监事 会第六次会议的通知于 2024 年 6 月 2 日以邮件、电话等方式向各位监事发出， 并于 2024 年 6 月 7 日在公司二楼会议室以现场与通讯相结合的方式召开。会议 应到监事3名，实到监事3名。会议的召开及表决符合《中华人民共和国公司法》、 《创业慧康科技股份有限公司章程》等有关规定。 经表决，形成如下决议： 一、审议通过了《关于调整 2022 年限制性股票激励计划相关事项的议案》 经审核，监事会认为：本次调整符合《上市公司股权激励管理办法》及《2022 年限制性股票激励计划（草案）》的相关规定。 经审核，监事会认为：本次委托全资子公司杭州合美物业管理有限公司以市 场化方式出租位于杭州市滨江区长河街道越达巷 92 号的物业，有助于提升公司 资产使用率，不存在损害公司和全体股东利益的情形。 表决结果：同意 3 票，反对 ...